Endava (NYSE:DAVA) Price Target Raised to $35.00

Endava (NYSE:DAVAFree Report) had its price objective increased by Morgan Stanley from $33.00 to $35.00 in a research report report published on Friday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.

Several other equities analysts have also issued reports on the company. Bank of America initiated coverage on Endava in a research report on Friday, November 22nd. They issued a “neutral” rating and a $29.00 price target for the company. Guggenheim cut their price target on Endava from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Citigroup cut their price target on Endava from $30.00 to $27.00 and set a “neutral” rating for the company in a research note on Monday, October 28th. TD Cowen boosted their price objective on Endava from $35.00 to $36.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC boosted their price target on Endava from $36.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $40.01.

Check Out Our Latest Stock Analysis on Endava

Endava Stock Down 0.0 %

Shares of NYSE DAVA opened at $32.47 on Friday. Endava has a one year low of $23.28 and a one year high of $73.27. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.90 and a quick ratio of 1.90. The firm’s 50 day simple moving average is $30.69 and its two-hundred day simple moving average is $29.09. The stock has a market capitalization of $1.92 billion, a P/E ratio of 231.91, a PEG ratio of 2.32 and a beta of 1.22.

Hedge Funds Weigh In On Endava

A number of hedge funds and other institutional investors have recently made changes to their positions in DAVA. Blue Trust Inc. lifted its stake in shares of Endava by 28.5% during the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock worth $46,000 after purchasing an additional 331 shares during the last quarter. Precision Wealth Strategies LLC lifted its stake in shares of Endava by 4.5% during the 4th quarter. Precision Wealth Strategies LLC now owns 8,954 shares of the company’s stock worth $277,000 after purchasing an additional 383 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Endava by 86.4% during the 4th quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock worth $50,000 after purchasing an additional 745 shares during the last quarter. Signaturefd LLC raised its stake in Endava by 84.1% in the third quarter. Signaturefd LLC now owns 1,939 shares of the company’s stock valued at $50,000 after buying an additional 886 shares during the last quarter. Finally, Strengthening Families & Communities LLC raised its stake in Endava by 11.4% in the third quarter. Strengthening Families & Communities LLC now owns 9,116 shares of the company’s stock valued at $233,000 after buying an additional 933 shares during the last quarter. Institutional investors own 62.23% of the company’s stock.

Endava Company Profile

(Get Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Further Reading

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.